BF Biosciences Balance Sheet Health
Financial Health criteria checks 3/6
BF Biosciences has a total shareholder equity of PKR2.3B and total debt of PKR2.2B, which brings its debt-to-equity ratio to 96.3%. Its total assets and total liabilities are PKR5.9B and PKR3.6B respectively. BF Biosciences's EBIT is PKR629.5M making its interest coverage ratio 8.8. It has cash and short-term investments of PKR541.3M.
Key information
96.3%
Debt to equity ratio
PK₨2.20b
Debt
| Interest coverage ratio | 8.8x |
| Cash | PK₨541.32m |
| Equity | PK₨2.29b |
| Total liabilities | PK₨3.59b |
| Total assets | PK₨5.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BFBIO's short term assets (PKR1.7B) exceed its short term liabilities (PKR1.4B).
Long Term Liabilities: BFBIO's short term assets (PKR1.7B) do not cover its long term liabilities (PKR2.2B).
Debt to Equity History and Analysis
Debt Level: BFBIO's net debt to equity ratio (72.6%) is considered high.
Reducing Debt: Insufficient data to determine if BFBIO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: BFBIO's debt is well covered by operating cash flow (31.1%).
Interest Coverage: BFBIO's interest payments on its debt are well covered by EBIT (8.8x coverage).